Results 21 to 30 of about 200,189 (245)

Using blood cytokine measures to define high inflammatory biotype of schizophrenia and schizoaffective disorder

open access: yesJournal of Neuroinflammation, 2017
Background Increases in pro-inflammatory cytokines are found in the brain and blood of people with schizophrenia. However, increased cytokines are not evident in all people with schizophrenia, but are found in a subset.
Danny Boerrigter   +11 more
doaj   +1 more source

Differences in inflammatory marker profiles and cognitive functioning between deficit and nondeficit schizophrenia

open access: yesFrontiers in Immunology, 2022
Deficit schizophrenia (DS) patient is a homogenous subtype of schizophrenia that includes primary and enduring negative symptoms. This study aimed to compare the differences in cognitive functioning and plasma levels of C-reactive protein (CRP) and ...
Dandan Wang   +8 more
doaj   +1 more source

Decoding schizophrenia across cultures: Clinical, epidemiological and aetiological issues [PDF]

open access: yes, 2012
This thesis was submitted for the degree of Doctor of Philosophy and awarded by Brunel University.There is accumulating epidemiological evidence of cross-ethnic differences in relation to schizophrenia’s incidence and prevalence.
Shalhoub, Huda
core   +7 more sources

Rethinking Schizophrenia in the Context of Normal Neurodevelopment

open access: yesFrontiers in Cellular Neuroscience, 2013
The schizophrenia brain is differentiated from the normal brain by subtle changes, with significant overlap in measures between normal and disease states. For the past 25 years, schizophrenia has increasingly been considered a neurodevelopmental disorder.
Vibeke Sorensen Catts   +39 more
doaj   +1 more source

Nuclear factor kappa B activation appears weaker in schizophrenia patients with high brain cytokines than in non-schizophrenic controls with high brain cytokines

open access: yesJournal of Neuroinflammation, 2020
Background High inflammation status despite an absence of known infection characterizes a subpopulation of people with schizophrenia who suffer from more severe cognitive deficits, less cortical grey matter, and worse neuropathology. Transcripts encoding
Caitlin E. Murphy   +7 more
doaj   +1 more source

Cost of treatment in schizophrenia in six European countries [PDF]

open access: yes, 2009
Background and aims: As part of an RCT in six European sites, the direct mental health care cost for 422 patients with schizophrenia was analysed according to how total and medication costs differed across sites and which variables were likely to predict
McCabe, R   +56 more
core   +2 more sources

Cannabidiol versus risperidone for treatment of recent-onset psychosis with comorbid cannabis use: study protocol for a randomized controlled clinical trial

open access: yesBMC Psychiatry, 2021
Background Cannabis use is an important risk factor for development of psychosis and further transition to schizophrenia. The prevalence of patients with psychosis and comorbid cannabis use (dual diagnosis) is rising with no approved specialized ...
Jesper Østrup Rasmussen   +4 more
doaj   +1 more source

Local and global limits on visual processing in schizophrenia. [PDF]

open access: yes, 2015
Schizophrenia has been linked to impaired performance on a range of visual processing tasks (e.g. detection of coherent motion and contour detection).
Steven C. Dakin   +33 more
core   +2 more sources

Abnormal Task Modulation of Oscillatory Neural Activity in Schizophrenia

open access: yesFrontiers in Psychology, 2013
Schizophrenia patients have deficits in cognitive function that are a core feature of the disorder. AX-CPT is commonly used to study cognition in schizophrenia, and patients have characteristic pattern of behavioral and ERP response.
Elisa C Dias   +6 more
doaj   +1 more source

Family-based association study of SELENBP1 in schizophrenia

open access: yes, 2009
The SELENBP1 gene previously was found to be up-regulated in microarray analysis of both peripheral blood cell and brain tissue samples from schizophrenia patients Quantitative PCR analysis subsequently corroborated the altered expression of SELENBP1 in ...
Kanazawa, Tetsufumi; Glatt, Stephen J.; Faraone, Stephen V.; Hwu, Hai-Gwo; Yoneda, Hiroshi; Tsuang, Ming T.   +1 more
core   +1 more source

Home - About - Disclaimer - Privacy